VIKAASH MADHAV PERSAD
SCRANTON, PA
Browse related groups: PA Acerta Pharma LLC All categories
This page merges CMS profile IDs: 5706563, 7233219 (associated profiles published by CMS for the same provider; see the provenance section below).
General Payments — all program years on this page
$701.80
- Category: General Payments
- Program years: PY2018–2020
- Record count: 12
- As of (CMS publication): 2026-01-23
Latest program year (PY2020): $333.93 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2020) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $333.93 | 8 |
By paying entity
Latest program year (PY2020) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $259.25 | 4 |
| Amgen Inc. | $29.93 | 1 |
| SANOFI-AVENTIS U.S. LLC | $18.61 | 1 |
| Novo Nordisk AS | $14.99 | 1 |
| GlaxoSmithKline, LLC. | $11.15 | 1 |
By program year
Records — PY2020 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 735811559 | AstraZeneca Pharmaceuticals LP | $121.24 | 02/12/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 736101551 | AstraZeneca Pharmaceuticals LP | $18.75 | 06/25/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 736373761 | AstraZeneca Pharmaceuticals LP | $55.93 | 06/18/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 736412071 | AstraZeneca Pharmaceuticals LP | $63.33 | 06/24/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 738582147 | GlaxoSmithKline, LLC. | $11.15 | 01/30/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 741346379 | Amgen Inc. | $29.93 | 06/04/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 744107283 | SANOFI-AVENTIS U.S. LLC | $18.61 | 06/12/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 744697081 | Novo Nordisk Inc | $14.99 | 04/30/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2020_P01232026_01102026.csv
- Merged CMS profile IDs: 5706563, 7233219
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.